From MarketWatch, December 2:
Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer.
Analysts said the move will support the German company’s attempts to resolve litigation around what’s called glyphosate by the end of 2026. Solicitor General D. John Sauer on Monday said the Environmental Protection Agency repeatedly has stated that glyphosate is not likely to be carcinogenic in humans and that the agency has repeatedly approved Roundup labels without cancer warnings.
Bayer welcomed the support in the lawsuit, Monsanto Co. vs. Durnell, and the issue of whether a federal insecticide rule preempts state law. Bayer said “tens of thousands” of cases on Roundup are overwhelmingly based on claims grounded in failure-to-warn theories....
....MORE
